One very useful application which I am interested in would be pressure sores. If these get big enough they often require flap surgery and the patients are generally in poor condition. If they can show it works for this then there is a large potential market in this particular area of elderly hospitalised patients. It would be one of the most common potential applications.
Ann: First US Surgeon Podium presentations of Novosorb BTM, page-10
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.29 |
Change
-0.010(0.43%) |
Mkt cap ! $1.553B | |||
| Open | High | Low | Value | Volume |
| $2.33 | $2.34 | $2.24 | $2.151M | 944.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 9090 | $2.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.29 | 15253 | 5 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| PNV (ASX) Chart |